1. Introduction {#sec1-ijerph-14-00737}
===============

For centuries, people living in Africa have been facing various infectious tropical illnesses, among which African trypanosomiases are some of the most frequent relevant parasitic diseases. African trypanosomiases, commonly called sleeping sickness in humans (HAT; Human African Trypanosomiasis) and Nagana in domestic livestock, affect a huge number of people living in poverty in 36 sub-Saharan countries and hence have a key socioeconomic impact \[[@B1-ijerph-14-00737],[@B2-ijerph-14-00737],[@B3-ijerph-14-00737]\]. After a century of outbreaks, due to political instability and a lack of funding, around 70 million people and 50 million cattle are still at risk of exposure in Africa \[[@B4-ijerph-14-00737]\].

Trypanosomiasis is transmitted by the bite of insects from the *Glossina* spp. (Glossinidae) and is fatal in humans, if untreated. While taking a blood meal, infected *Glossina* flies can spread extracellular protozoans from the species *Trypanosoma brucei.* There are three morphologically indistinguishable subspecies of *T. brucei*. The subspecies *T. b. gambiense* is responsible for a chronic form of the human disease, while *T. b. rhodesiense* causes an acute form, which more rapidly leads to death. Both subspecies are infective to humans, whereas *T. b. brucei* is only infective to animals. During the early stage of the disease or the hemolymphatic phase, the parasite is restricted to the blood and lymph, and, after months or years, it invades the central nervous system, resulting in various neurological symptoms, including sleeping disturbance \[[@B3-ijerph-14-00737]\].

As for other neglected tropical diseases, the chemotherapeutical arsenal against HAT is based on limited, expensive, and often toxic medicines that are administered parentally in a context of poverty and a lack of qualified personnel in healthcare centers. The few drugs that are available are pentamidine and suramin for the early stage of the disease and eflornithine (also in combination with nifurtimox) and melarsoprol, an organoarsenic compound, for the late stage, when the parasite infects the brain. Although melarsoprol can cause severe reactive encephalopathy, it remains a first line treatment for infections by *T. b. gambiense* in many rural areas because of the high cost of eflornithine \[[@B1-ijerph-14-00737]\]. Overall, the scenario described above highlights the critical nature of the current situation and the urgent need to explore new sources of potentially effective and safe compounds for therapy.

It has been estimated that a large part of the African population relies on herbal medicines as the first-line treatment for different ailments. In this regard, the African flora represents a valuable source of anti-infectious compounds to be exploited as drugs \[[@B5-ijerph-14-00737],[@B6-ijerph-14-00737],[@B7-ijerph-14-00737]\]. In the fight against *Trypanosoma* infections, new therapeutic options can be provided by plant extracts, essential oils, and plant-borne compounds \[[@B6-ijerph-14-00737],[@B8-ijerph-14-00737],[@B9-ijerph-14-00737],[@B10-ijerph-14-00737]\]. Essential oils are volatile mixtures distilled from aromatic plants and composed of several dozens of components such as terpenoids, phenylpropanoids, and aliphatic compounds \[[@B11-ijerph-14-00737],[@B12-ijerph-14-00737]\]. In recent years, an increasing interest on essential oils as alternative/integrative therapies in the treatment of HAT has been observed \[[@B13-ijerph-14-00737]\]. Essential oils and representative components from lemongrass (*Cymbopogon citratus* (DC.) Stapf), oregano (*Origanum vulgare* L.), thyme (*Thymus vulgaris* L.), clove (*Syzygium aromaticum* (L.) Merr. and L.M. Perry), basil (*Ocimum basilicum* L.), and yarrow (*Achillea millefolium* L.) exhibited efficacy both in in vitro and in vivo models of trypanosomal infections \[[@B14-ijerph-14-00737]\]. Essential oils are composed of a plethora of chemical compounds, which have various modes of action on microorganisms, and, additionally, essential oils do not induce any form of resistance \[[@B15-ijerph-14-00737]\].

In the present study, we selected a panel of Cameroonian medicinal and aromatic plants as potential sources of anti-trypanocidal compounds. We focused on *Azadirachta indica* A. Juss (Meliaceae), *Aframomum melegueta* K. Schum. (Zingiberaceae), *Aframomum daniellii* (Hook. F.) K. Schum. (Zingiberaceae), *Clausena anisata* (Willd.) Hook.f. ex Benth. (Rutaceae), *Dichrostachys cinerea* (L.) Wight and Arn. (Mimosaceae), and *Echinops giganteus* A. Rich. (Asteraceae).

*A. indica*, also known as 'neem tree', is considered by many people living in Africa as a miraculous plant for a wide range of uses in ethnopharmacology such as anthelmintic, antimalarial, anti-inflammatory purposes and for healing skin diseases. Most of these properties were then confirmed by scientific reports \[[@B16-ijerph-14-00737],[@B17-ijerph-14-00737],[@B18-ijerph-14-00737]\]. All parts of the plant can be used for medicinal purposes, including the seed oil extracted by mechanical pressure \[[@B19-ijerph-14-00737],[@B20-ijerph-14-00737]\]. Notably, the ethanolic extract obtained from neem stem bark exhibited activity against *T. b. brucei* \[[@B21-ijerph-14-00737]\], whereas the leaf essential oil has been barely investigated to date.

*A. melegueta,* also known as 'alligator pepper' or 'grain of paradise', is a perennial plant native to western Africa, and its seeds are used as a spice in food due to their aromatic flavor and pungent taste or as ingredients of ethnomedical preparations for the treatment of snakebites, stomachaches, and diarrhea \[[@B22-ijerph-14-00737]\]. Antimicrobial, anti-inflammatory, anticancer, and antioxidant properties have been reported for alligator pepper \[[@B23-ijerph-14-00737]\]. Concerning seed volatile constituents, they showed repellent activity against adults of the maize weevil *Sitophilus zeamais* \[[@B24-ijerph-14-00737]\].

*A. daniellii*, also known as 'African cardamom', is an herbaceous plant traditionally used in Africa as a spice due to the pungent taste of its seeds, whereas, for medicinal purposes, the plant is employed as a laxative and for curing parasitic and other microbial infections \[[@B25-ijerph-14-00737],[@B26-ijerph-14-00737]\]. The anti-inflammatory effect of its seed essential oil and the preservative properties in stored grains have also been reported \[[@B27-ijerph-14-00737],[@B28-ijerph-14-00737]\].

*C. anisata* is an evergreen tropical tree up to 10 m tall with leaves containing secretory glands and emitting a strong smell \[[@B29-ijerph-14-00737]\]. In Africa, it is considered highly effective against insects and has also been used in the treatment of malaria \[[@B30-ijerph-14-00737]\].

*D. cinerea* is a tree growing in tropical areas in countries such as Cameroon, Kenya, South Africa, and Tanzania, where a decoction of its leaves and roots is used against venereal disease, eye inflammations, skin diseases, and snake bites. The root is used for chest complaints and the twigs for gonorrhoea and syphilis. The essential oil was toxic to mosquito vectors of bancroftian filariasis \[[@B26-ijerph-14-00737]\].

*E. giganteus* is a perennial herb widely used in African traditional medicine for the treatment of various ailments \[[@B31-ijerph-14-00737],[@B32-ijerph-14-00737]\]. In previous studies, the root methanolic extract showed significant antibacterial \[[@B33-ijerph-14-00737]\], antifungal \[[@B34-ijerph-14-00737]\], and antioxidant effects \[[@B35-ijerph-14-00737]\]. The cytotoxicity of the crude methanol extract from the roots has also been demonstrated \[[@B36-ijerph-14-00737],[@B37-ijerph-14-00737]\].

Overall, these Cameroonian plants are also traditionally used to control populations of arthropod pests \[[@B38-ijerph-14-00737],[@B39-ijerph-14-00737],[@B40-ijerph-14-00737]\]. In this research, we shed light on the growth inhibitory potential of the essential oils obtained from the leaves of *A. indica*, *A. daniellii*, and *C. anisata*; the seeds of *A. melegueta* and *D. cinerea*; and the roots of *E. giganteus* against *T. brucei* TC221. Selected pure constituents from the above mentioned essential oils were also evaluated.

2. Materials and Methods {#sec2-ijerph-14-00737}
========================

2.1. Plant Material {#sec2dot1-ijerph-14-00737}
-------------------

Leaves of *A. indica* were collected during the dry season (January 2016) from a tree in the city of Guidiguis (north of Cameroon), about 70 km from Maroua. The leaves were air-dried in the shade for one week and kept in papers. Fruits (pods) of *A. melegueta* were collected in a forest near Foumbam (western Cameroon) in December 2015. Once harvested, the seeds were removed from their pods and dried at room temperature over a period of three weeks in the absence of sunlight. At the end of the drying process, the seeds were placed into paper bags before hydrodistillation. Leaves of *C. anisata* were collected in the village of Baffou, Menoua Division, Western Cameroon. Leaves of *A. danielli* and fruits of *D. cinerea* and roots of *E. giganteus* were collected from Bamougoum and Bafoussam's market (Cameroon, Western Region), respectively. The pericarp of *D. cinerea* was removed and the seeds used; the roots of *E. giganteus* were washed with water and sliced into small pieces. These plant parts were dried at room temperature for one week. The botanical identification of the five species was performed by a taxonomist at the Cameroon National Herbarium (Yaoundé, Cameroon), and the voucher specimens were archived with the following codes: 4447 SRFK (*A. indica*), 43117 HNC (*A. melegueta*), 43130 HNC (*A. danielli*), 44242/HNC (*C. anisata*), 42920 HNC (*D. cinerea*), and 23647 SRF (*E. giganteus*). The botanical names were also checked against The Plant List database ([www.theplantlist.org](www.theplantlist.org)).

2.2. Isolation of Essential Oil {#sec2dot2-ijerph-14-00737}
-------------------------------

The dry leaves of *A. indica, A. daniellii*, and *C*. *anisata*; the seeds of *A. melegueta* and *D. cinerea*; and the roots of *E. giganteus* were cut into small pieces and subjected to hydrodistillation using a Clevenger-type apparatus until no more oil was obtained. The essential oils obtained were dried using Na~2~SO~4~ and stored at −20 °C in vials sealed with teflon caps and protected from light before use. The oil yields were calculated on a dry weight basis (%, *w/w*).

2.3. Chemicals {#sec2dot3-ijerph-14-00737}
--------------

For the identification of volatiles, the following analytical standards purchased from Sigma Aldrich (Milan, Italy) were used: α-pinene, β-pinene, sabinene, 1,8-cineole, camphene, myrcene, α-phellandrene, δ-3-carene, *p*-cymene, limonene, γ-terpinene, terpinolene, linalool, *trans*-pinocarveol, terpinen-4-ol, α-terpineol, myrtenal, citronellol, isobornyl acetate, (*E*)-caryophyllene, α-humulene, (*E*)-β-ionone, and caryophyllene oxide. The reference drug suramin was purchased from Sigma Aldrich.

2.4. Gas Chromatography--Mass Spectrometry (GC-MS) Analysis of Essential Oils {#sec2dot4-ijerph-14-00737}
-----------------------------------------------------------------------------

The chemical constituents of the Cameroonian essential oils were analyzed on an Agilent 6890 N gas chromatograph coupled to a 5973 N mass spectrometer (Santa Clara, CA, USA) and equipped with a HP-5 MS capillary column (5% phenylmethylpolysiloxane, 30 m, 0.25 mm i.d., 0.1 μm film thickness; J & W Scientific, Folsom, CA, USA). For the separation of the volatile constituents, the following temperature program was used: 5 min at 60 °C then 4 °C/min up to 220 °C, then 11 °C/min up to 280 °C held for 15 min. The injector and detector temperatures were: 280 °C; carrier gas: Helium; flow rate: 1 mL/min; split ratio: 1:50; acquisition mass range: 29--400 *m/z*; and mode: electron-impact (EI, 70 eV). The essential oil was diluted 1:100 in *n*-hexane, and then 2 µL of the solution was injected into the GC-MS system. For the identification of essential oil components, co-injection with the authentic standards available in our laboratory (purchased from Sigma-Aldrich) was performed, together with a comparison of the retention indices and the mass spectra of those occurring in the ADAMS, NIST 08, and FFNSC2 libraries \[[@B41-ijerph-14-00737],[@B42-ijerph-14-00737],[@B43-ijerph-14-00737]\]. The percentage values of the volatile components were the means of three chromatographic analyses and were determined from the peak areas without the use of correction factors.

2.5. T. brucei and Mammalian Cell Culture and Growth Inhibition Assay {#sec2dot5-ijerph-14-00737}
---------------------------------------------------------------------

The cell culture conditions and the growth inhibition assay on *T. brucei* and Balb/3T3 cells were performed as described before \[[@B44-ijerph-14-00737]\]. *T. brucei* TC221 bloodstream forms and mouse embryonic fibroblast Balb/3T3 cells (ATCC no CCL-163) were cultivated in vented plastic flasks at 37 °C with 5% CO~2~. For *T. brucei*, the growth medium was HMI-9 \[[@B45-ijerph-14-00737]\] supplemented with 10% (*v/v*) fetal bovine serum (Gibco, Waltham, MA, USA), whereas the Balb/3T3 cells were grown in Dulbecco's Modified Eagle's Medium (Sigma-Aldrich) supplemented with 10% (*v/v*) heat-inactivated fetal bovine serum, glutamine (0.584 g/L), and 10 mL/L 100× penicillin-streptomycin (Gibco).

The essential oils or pure compounds identified from these oils were dissolved in dimethyl sulfoxide (DMSO) and serially diluted with growth medium in white 96-well microtiter plates. 20,000 bloodstream forms of *T. brucei* or Balb/3T3 cells were added to each well in a final volume of 200 μL. In the case of mammalian cells, we also tested 2000 cells/well with similar results. To avoid any damage to the cells, the concentration of DMSO in the solution was never higher than 1% (no cell growth inhibition was observed with this concentration of DMSO). Cell viability was verified by a drug-free control for each compound.

The plates were incubated for 48 h in the CO~2~ incubator; then 20 μL of 0.5 mM resazurine (Sigma Aldrich) was added to each well, and the plates were incubated for an additional 24 h before the fluorescence was measured with an Infinite M200 microplate reader (Tecan group, Ltd., Männedorf, Switzerland) equipped with 540 and 590 nm excitation and emission filters. The half maximal inhibitory concentration (IC~50~) values were calculated on a log inhibitor versus the response curves by non-linear regression using the GraphPad prism 5.04 software (GraphPad Software, Inc., La Jolla, CA, USA).

3. Results and Discussion {#sec3-ijerph-14-00737}
=========================

3.1. Chemical Composition of Essential Oils from Cameroonian Plants {#sec3dot1-ijerph-14-00737}
-------------------------------------------------------------------

The chemical composition of the essential oils hydrodistilled from the six Cameroonian medicinal and aromatic plants is reported in [Table 1](#ijerph-14-00737-t001){ref-type="table"}. In the essential oil obtained from neem leaves, a total of thirteen components were identified, accounting for 98.3% of the total composition. The oil was almost entirely composed by sesquiterpene hydrocarbons (97.4%), with germacrene B (74.0%) and γ-elemene (18.3%) as the predominant components. The minor constituents were (*E*)-caryophyllene (2.4%) and β-elemene (0.9%). This work represents one of the few studies on the chemical composition of neem leaf essential oils. Neem trees have been largely investigated for the oil obtained by mechanical pressure or solvent extraction from their seeds. Earlier, El-Hawary et al. \[[@B46-ijerph-14-00737]\] studied the composition of Egyptian neem leaves, reporting β-elemene (33.39%), γ-elemene (9.89%), germacrene D (9.72%), caryophyllene (6.8%), and bicyclogermacrene (5.23%) as the major compounds, while Dastan et al. \[[@B47-ijerph-14-00737]\] found γ-elemene (20.8%), germacrene B (20.3%), *trans*-caryophyllene (13.5%), hexadecanal (12.8%), and methyl linoleate (10.5%) as the major compounds in neem leaf oil from Iran.

A total of fifty-nine components were identified in the essential oil of alligator pepper, accounting for 99.4% of the total composition. The oil was dominated by oxygenated monoterpenes (83.3%), with 1,8-cineole (58.5%) and α-terpineol (19.4%) as the major compounds. Monoterpene hydrocarbons gave a minor contribution (14.9%), with β-pinene (7.1%) and α-pinene (2.0%) as the most representative compounds. Interestingly, sesquiterpenoids, which are reported as volatile marker compounds of alligator pepper, were detected in only low levels here (0.6%). The chemical composition of the *A. melegueta* seed essential oil showed a significant variability depending on the geographic origin and genetic characteristics of the samples. For example, samples from Nigeria exhibited humulene (26.23%), (*E*)-ocimene (23.22%), (*E*)-caryophyllene (19.17%), and (*S*)-2-heptyl acetate (16.22%) as the major volatile constituents \[[@B24-ijerph-14-00737]\]. On the other hand, the seeds from the Central African Republic contained high levels of β-pinene (\>30%) and about 50% sesquiterpene hydrocarbons \[[@B48-ijerph-14-00737]\], and an oil sample from Cameroon was made up of β-caryophyllene (8.5%), α-humulene (31.3%), and their epoxides (17.9% and 27.7%, respectively) \[[@B49-ijerph-14-00737]\].

Fifty-seven compounds were identified in the essential oil from African cardamom leaves, accounting for 99.3% of the total composition. This oil was mainly made up of monoterpene hydrocarbons (59.8% in leaves), accompanied by lower amounts of sesquiterpene hydrocarbons (20.0%), oxygenated monoterpenes (11.0%), and oxygenated sesquiterpenes (8.4%). The major compounds were sabinene (43.9%) and (*E*)-caryophyllene (16.6%), whereas other components occurring at noteworthy levels were β-pinene (5.8%), terpinen-4-ol (3.7%), and α-pinene (2.4%). This study was the first report on the leaf essential oil from *A. daniellii*.

The essential oil extracted from the leaves of *C. anisata* was characterized by high levels of phenylpropanoids (84.0%), which were mainly represented by (*E*)-anethole (64.6%), with minor contributions by (*E*)-methyl isoeugenol (16.1%) and methyl chavicol (2.0%). Terpenoids constituted a minor part of this oil, being represented mostly by *p*-cymene (2.9%), γ-terpinene (2.4%), myrcene (2.0%), and germacrene D (2.2%).

In the essential oil of *D. cinerea* seeds, a total of forty-nine volatile components were identified, accounting for 76.0% of the oil's composition. Oxygenated monoterpenes were the most abundant constituents (50.6%), with geraniol (18.2%), terpinen-4-ol (7.5%), linalool (4.0%), and umbellulone (3.8%) as the most representative compounds. Oxygenated sesquiterpenes gave a lower contribution (12.1%), with none of the identified components exceeding 1.8%. Among other components occurring in the oil, it is worth noting the presence of ligustrazin (5.1%), elemicin (3.0%), and decanoic acid (2.8%). To our knowledge, no previous research has reported the chemical composition of *D. cinerea* seed essential oil.

Thirty-five volatile compounds, all belonging to the sesquiterpene class (94.3%), were identified in the root essential oil from *E. giganteus* (54.7% sesquitepene hydrocarbons and 39.6% oxygenated sesquiterpenes). The major compounds were tricyclic sesquiterpenoids, which are characterized by multiple rearrangements of the caryophyllene cation \[[@B50-ijerph-14-00737],[@B51-ijerph-14-00737]\], namely, silphiperfol-6-ene (23.0%), presilphiperfolan-8-ol (22.7%), presilphiperfol-7-ene (7.8%), and cameroonan-7-α-l (7.8%). Another noteworthy constituent occurring in the oil was (*E*)-caryophyllene (6.3%). The cameroonan-7-α-l, is responsible for the patchouli-like smell of the root oil \[[@B52-ijerph-14-00737]\]. The reported composition was quite consistent with that previously reported by Menut et al. \[[@B49-ijerph-14-00737]\] for root samples collected in Cameroon.

3.2. Inhibition of Trypanosoma brucei Proliferation {#sec3dot2-ijerph-14-00737}
---------------------------------------------------

Essential oils are complex mixtures of volatile compounds with multitarget actions, the antitrypanosomal effects of which are largely unknown and barely explored. On this basis, we decided to test the in vitro inhibitory effects of a pool of essential oils taken from medicinal and aromatic plants growing in Cameroon. Some of them are known for their traditional uses in the treatment of infectious diseases and malaria \[[@B53-ijerph-14-00737],[@B54-ijerph-14-00737]\] and, in the case of the Neem tree, also against *T. b. brucei* \[[@B21-ijerph-14-00737]\].

Based on the chemical analysis performed, they exhibited different chemical profiles characterized by diverse functionalized groups such as monoterpene hydrocarbons (African cardamom), oxygenated monoterpenes (*A. melegueta* and *D. cinerea*), sesquiterpene hydrocarbons (*A. indica*), sesquiterpene hydrocarbons and oxygenated sesquiterpenes (*E. giganteus*), and phenylpropanoids (*C. anisata*). In this context, the main aim of our work was to identify the chemical scaffolds of possible natural lead compounds against trypanosomiasis.

Testing the essential oils obtained from Cameroonian plants, we obtained various degrees of inhibition on *T. brucei* proliferation, varying from not active (*A. melegueta*, *C. anisata*, and *D. cinerea*), to moderately active (*A. danielli*, *E. giganteus* and *A. indica*). Notably, the IC~50~ values on *T. brucei* were 7.65, 10.50, and 15.21 µg/mL for the essential oils from *A. danielli*, *E. giganteus*, and *A. indica*, respectively ([Table 2](#ijerph-14-00737-t002){ref-type="table"}). Furthermore, the most active oils were also evaluated for the growth inhibitory effects on Balb/3T3 cells as a reference. No effect on mammalian cells was observed with concentrations as high as 100 µg/mL, showing a noteworthy selectivity against *T. brucei* in comparison to mammalian cells, with selectivity indexes above 6.57 in all cases.

The inhibitory effects on *T. brucei* exhibited by the three essential oils highlights three classes of active compounds, i.e., monoterpene hydrocarbons (for *A. danielli*) and sesquiterpene hydrocarbons (for *A. indica* and *E. giganteus*) ([Figure 1](#ijerph-14-00737-f001){ref-type="fig"}). *E giganteus* also contains high amounts of oxygenated compounds.

The toxicity of monoterpene hydrocarbons against *T. brucei* can be attributed to the high hydrophobicity of this class of compounds, which are able to easily cross the cell membrane, causing the destabilization of phospholipid bilayers and the alteration of their permeability, leading to cell damage and death \[[@B44-ijerph-14-00737],[@B55-ijerph-14-00737]\]. Among these compounds, the most abundant was sabinene (43.9%) ([Figure 1](#ijerph-14-00737-f001){ref-type="fig"}) which showed an IC~50~ value against *T. brucei* of 5.96 µg/mL, which is close to that of the African cardamom essential oil (7.65 µg/mL) ([Table 2](#ijerph-14-00737-t002){ref-type="table"}). Another component of this oil with detectable antitrypanosomal activity was β-pinene, showing an IC~50~ value of 11.4 µg/mL. The antitrypanosomal activity of sabinene was already reported in a previous study, although its mechanism of action on the protozoal cell has not been elucidated \[[@B56-ijerph-14-00737]\].

*E. giganteus* as well as *A. daniellii* essential oils contained the bicyclic sesquiterpene (*E*)-caryophyllene ([Figure 1](#ijerph-14-00737-f001){ref-type="fig"}), which exhibited good inhibitory properties on *T. brucei* (IC~50~ value of 8.25 µg/mL). However, the content of this component is only 6.3% in *E. giganteus* and can therefore not explain the good activity of this essential oil. It is rather tricyclic sesquiterpenes that are the major constituent. This is the first report documenting the antitrypanosomal activity of the tricyclic sesquiterpenes-containing *E. giganteus* essential oil. The latter was a rich source of compounds such as silphiperfol-6-ene, presilphiperfolan-8-ol, presilphiperfol-7-ene, and cameroonan-7-α-l with an unusual skeleton ([Figure 1](#ijerph-14-00737-f001){ref-type="fig"}) \[[@B26-ijerph-14-00737]\]. To date, these compounds have not been biologically investigated. Previously, the tricyclic sesquiterpene ledol was suggested to be responsible for the trypanocidal properties of *Hagenia abyssinica* (Bruce ex Steud.) J.F.Gmel. essential oil \[[@B13-ijerph-14-00737]\].

Among the other pure compounds, 1,8-cineole and terpinen-4-ol were inactive against *T. brucei* (IC~50~ \> 100 µg/mL) ([Table 2](#ijerph-14-00737-t002){ref-type="table"}), and this also explained the lack of activity of the *A. melegueta* and *D. cinerea* essential oils, which are dominated by these compounds.

Finally, we demonstrated for the first time that the leaf essential oil from the neem tree, which showed an IC~50~ value of 15.21 µg/mL, can be a source of sesquiterpenes such as germacrene B and γ-elemene. Since this oil is completely dominated by sesquiterpenes (97.4%), it can be assumed that they are responsible for its antitrypanosomal activity. Further studies are needed to elucidate their mode of action and the possibility of them acting as lead compounds for the discovery of antitrypanosomal drugs.

4. Conclusions {#sec4-ijerph-14-00737}
==============

In conclusion, our biological investigation into the essential oils distilled from medicinal and aromatic plants growing in Cameroon identified some terpenoids as possible lead compounds of natural antitrypanosomal drugs. Further research is encouraged to disclose their mechanisms of action and in vivo efficacy.
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Chemical composition of the essential oils from *Azadirachta indica*, *Aframomum melegueta*, *Aframomum danielli*i, *Clausena anisata*, *Dichrostachys cinerea*, and *Echinops giganteus*.

  No.   Component ^a^                           RI calc. ^b^   RI lit. ^c^   \% ^d^   ID ^f^                               
  ----- --------------------------------------- -------------- ------------- -------- -------- ------ ------ ------ ------ -------
  1     isopentyl acetate                       873            869                    tr ^g^                               RI,MS
  2     2-methyl butyl acetate                  876            875                    tr                                   RI,MS
  3     2-heptanone                             891            892                    tr                                   RI,MS
  4     2-heptanol                              901            894                    0.2                                  RI,MS
  5     α-thujene                               916            924                    tr       1.0    0.1                  RI,MS
  6     α-pinene                                921            932                    2.0      2.4    0.2           tr     Std
  7     α-fenchene                              938            945                    0.1                                  RI,MS
  8     camphene                                939            946                    0.3      tr                          RI,MS
  9     sabinene                                959            969                    tr       43.9   0.6                  RI,MS
  10    β-pinene                                963            974                    7.1      5.8    0.3    0.1           Std
  11    dehydro-1,8-cineole                     979            988                    0.1                                  RI,MS
  12    myrcene                                 982            988                    0.2      1.5    2.0    0.3    tr     Std
  13    α-phellandrene                          996            1004                   0.3      tr                          Std
  14    δ-3-carene                              1003           1008                                                 tr     Std
  15    α-terpinene                             1009           1014                   0.3      0.9    tr                   RI,MS
  16    *p*-cymene                              1016           1020                   1.1      1.0    2.9    0.1           Std
  17    limonene                                1020           1024                   1.5      0.7    0.4    tr     tr     Std
  18    1,8-cineole                             1021           1026                   58.5     0.5    0.2    2.3           Std
  19    ethylhexanol                            1031           1030                                          0.2           RI,MS
  20    (*Z*)-β-ocimene                         1037           1032                                   0.4                  Std
  21    (*E*)-β-ocimene                         1041           1044                   0.1      0.3    0.3                  RI,MS
  22    γ-terpinene                             1050           1054                   0.9      1.9    2.4                  Std
  23    *cis*-sabinene hydrate                  1057           1065                            1.1                         RI,MS
  24    *cis*-linalool oxide                    1071           1067                                   tr     0.1           RI,MS
  25    terpinolene                             1079           1086                   0.8      0.4    0.1           tr     Std
  26    *p*-cymenene                            1086           1089                   0.2                                  RI,MS
  27    ligustrazin                             1081           1083                                          5.1           RI,MS
  28    *trans*-sabinene hydrate                1089           1098                            0.9                         RI,MS
  29    2-nonanone                              1094           1094                   tr                                   RI,MS
  30    linalool                                1096           1095                   tr       1.8    tr     4.0           Std
  31    *n*-nonanal                             1105           1100                   tr                                   RI,MS
  32    *endo*-fenchol                          1108           1114                   0.3                                  RI,MS
  33    *cis*-*p*-menth-2-en-1-ol               1113           1118                            0.2           0.3           RI,MS
  34    α-campholenal                           1123           1122                   tr                     0.1           RI,MS
  35    *trans*-pinocarveol                     1128           1135                   0.2                    0.7           Std
  36    *trans*-*p*-menth-2-en-1-ol             1131           1136                            0.1           0.3           RI,MS
  37    *cis*-β-terpineol                       1142           1140                   tr                                   RI,MS
  38    *cis*-verbenol                          1142           1137                                          0.2           RI,MS
  39    *trans*-pinocamphone                    1151           1158                                          0.4           RI,MS
  40    pinocarvone                             1152           1160                   tr                     0.1           RI,MS
  41    borneol                                 1156           1165                   0.2                    0.7           Std
  42    *p*-mentha-1,5-dien-8-ol                1158           1166                   1.1                                  RI,MS
  43    *cis*-pinocamphone                      1162           1172                                          0.8           RI,MS
  44    umbelullone                             1166           1167                                          3.8           RI,MS
  45    terpinen-4-ol                           1167           1174                   1.4      3.7    tr     7.5           Std
  46    *cis*-pinocarveol                       1175           1182                   tr                                   RI,MS
  47    cryptone                                1183           1183                   tr                                   RI,MS
  48    *p*-cymen-8-ol                          1178           1179                   tr              tr     0.3           RI,MS
  49    α-terpineol                             1181           1186                   19.4     0.2    tr     3.3           Std
  50    myrtenal                                1184           1195                   0.2      0.1           0.2           Std
  51    myrtenol                                1186           1194                   0.2      0.4           1.1           Std
  52    *cis*-piperitol                         1199           1195                            tr                          RI,MS
  53    γ-terpineol                             1195           1199                   tr                                   RI,MS
  54    methyl chavicol                         1196           1195                                   2.0                  RI,MS
  55    *trans*-piperitol                       1205           1207                                          0.1           RI,MS
  56    *trans*-carveol                         1217           1215                   tr                     0.2           RI,MS
  57    *cis*-carveol                           1228           1226                   tr                                   RI,MS
  58    thymol methyl ether                     1224           1232                   tr                                   RI,MS
  59    nerol                                   1229           1227                                          0.2           Std
  60    citronellol                             1231           1223                                          0.3           Std
  61    carvone                                 1240           1239                   tr                                   Std
  62    carvacrol methyl ether                  1237           1241                   tr                                   RI,MS
  63    neral                                   1241           1235                                          0.2           Std
  64    piperitone                              1250           1249                                          0.3           RI,MS
  65    (*Z*)-anethole                          1250           1249                                   0.3                  RI,MS
  66    *p*-anisaldehyde                        1251           1247                                   0.7                  RI,MS
  67    geraniol                                1251           1249                                          18.2          Std
  68    *trans*-ascaridol glycol                1262           1266                            tr                          RI,MS
  69    (*E*)-cinnamaldehyde                    1267           1267                   tr                                   RI,MS
  70    phellandral                             1269           1273                   0.1                                  RI,MS
  71    isobornyl acetate                       1276           1283                            tr                          Std
  72    (*E*)-anethole                          1287           1282                                   64.6                 Std
  73    thymol                                  1291           1289                   0.1                    0.9           Std
  74    *trans*-sabinyl acetate                 1291           1289                            tr                          RI,MS
  75    methyl myrtenate                        1292           1293                                          2.0           RI,MS
  76    carvacrol                               1301           1298                   0.5             tr     0.7           Std
  77    *cis*-pinocarvyl acetate                1303           1311                            0.1                         RI,MS
  78    myrtenyl acetate                        1316           1324                            1.9                         RI,MS
  79    silphiperfol-5-ene                      1318           1326                                                 2.1    RI,MS
  80    δ-elemene                               1326           1335          0.1                      0.1                  RI,MS
  81    presilphiperfol-7-ene                   1328           1334                                                 7.8    RI,MS
  82    silphinene                              1333           1340                                                 1.7    RI,MS
  83    7-*epi*-silphiperfol-5-ene              1336           1349                                                 3.5    RI,MS
  84    α-terpinyl acetate                      1341           1346                   tr                     0.3           RI,MS
  85    α-copaene                               1362           1374          0.2               0.2    tr                   Std
  86    β-bourbonene                            1369           1387          0.3               tr                          RI,MS
  87    modheph-2-ene                           1362           1382                                                 3.0    RI,MS
  88    silphiperfol-6-ene                      1373           1377                                                 23.0   RI,MS
  89    β-bourbonene                            1377           1387                                   0.1                  RI,MS
  90    β-cubebene                              1377           1387                            tr                          RI,MS
  91    α-isocomene                             1379           1387                                                 2.4    RI,MS
  92    β-elemene                               1380           1389          0.9               tr     0.1                  Std
  93    decanoic acid                           1380           1386                                          2.8           RI,MS
  94    anisyl methyl ketone                    1382           1380                                   0.1                  RI,MS
  95    *iso*-longifolene                       1383           1389                                                 tr     RI,MS
  96    β-isocomene                             1400           1407                                                 2.1    RI,MS
  97    α-gurjunene                             1400           1409                                                 tr     Std
  98    (*E*)-caryophyllene                     1402           1417          2.4      tr       16.6   0.8           6.3    Std
  99    methyl eugenol                          1406           1403                                   0.3                  RI,MS
  100   α-*trans*-bergamotene                   1425           1432                            0.1                         RI,MS
  101   isoamyl benzoate                        1433           1433                   tr                                   RI,MS
  102   γ-elemene                               1427           1434          18.3                     0.1                  RI,MS
  103   α-humulene                              1436           1452          0.4      tr       1.5    0.8           2.0    Std
  104   geranyl acetone                         1449           1453                                          1.2           RI,MS
  105   (*E*)-β-farnesene                       1450           1454                            tr                   tr     RI,MS
  106   germacrene D                            1465           1484          0.5               0.3    2.2           0.3    RI,MS
  107   selina-4,11-diene                       1467           1474                            0.1                         RI,MS
  108   β-selinene                              1469           1489                   tr                                   RI,MS
  109   *ar*-curcumene                          1472           1479                                   tr            0.1    RI,MS
  110   bicyclogermacrene                       1480           1500                            0.1    0.1                  RI,MS
  111   benzaldehyde, 3,4-dimethoxy-            1482           1489                                   0.2                  RI,MS
  112   (*E*)-β-ionone                          1481           1487          0.5                                           Std
  113   *epi*-cubebol                           1489           1493                                                 0.1    RI,MS
  114   α-zingiberene                           1492           1493                                   0.1                  RI,MS
  115   (*Z*)-α-bisabolene                      1493           1506                            0.1                         RI,MS
  116   silphiperfolan-6-α-ol                   1496           1507                                                 1.0    RI,MS
  117   β-bisabolene                            1498           1505                            0.9                         RI,MS
  118   (*E*)-methyl isoeugenol                 1499           1491                                   16.1                 RI,MS
  119   cameroonan-7-α-ol                       1500           1510                                                 7.1    RI,MS
  120   β-bisabolene                            1506           1505                                   0.3                  RI,MS
  121   7-*epi*-α-selinene                      1507           1520                   tr                                   RI,MS
  122   (*E*,*E*)-α-farnesene                   1508           1505                                   0.3                  Std
  123   *trans*-calamenene                      1508           1521                            tr                          RI,MS
  124   *δ*-cadinene                            1510           1522          0.2               tr     0.1           0.3    RI,MS
  125   silphiperfolan-7-β-ol                   1510           1519                                                 2.5    RI,MS
  126   β-sesquiphellandrene                    1520           1521                                   tr                   RI,MS
  127   selina-3,7(11)-diene                    1531           1545          0.2                                           RI,MS
  128   silphiperfolan-6-β-ol                   1535           1546                                                 1.7    RI,MS
  129   hedycaryol                              1536           1546                            1.5                         RI,MS
  130   germacrene B                            1546           1559          74.0                     0.3                  RI,MS
  131   elemicin                                1556           1555                                          3.0           RI,MS
  132   (*E*)-nerolidol                         1556           1561                            0.7                         Std
  133   isoaromadendrene epoxide                1560           1572                                          1.8           RI,MS
  134   prenopsan-8-ol                          1564           1575                                                 3.2    RI,MS
  135   caryophyllene oxide                     1564           1582                            2.2           1.1           Std
  136   (3*Z*)-hexenyl benzoate                 1566           1565          0.3                                           RI,MS
  137   spathulenol                             1568           1576                                   0.1                  RI,MS
  138   presilphiperfolan-8-ol                  1578           1585                                                 22.7   MS
  139   guaiol                                  1583           1600                            0.5                         RI,MS
  140   humulene epoxide II                     1590           1608                            0.1    tr                   RI,MS
  141   10-*epi*-γ-eudesmol                     1600           1622                   tr       0.3                         RI,MS
  142   eremoligenol                            1611           1629                            0.4                         RI,MS
  143   γ-eudesmol                              1615           1630                   tr       0.4                         RI,MS
  144   1,10-di-*epi*-cubenol                   1619           1618                                                 0.1    RI,MS
  145   β-eudesmol                              1631           1649                   0.2      1.5                         RI,MS
  146   α -acorenol                             1628           1632                                          1.0           RI,MS
  147   caryophylla-4(12),8(13)-dien-5-ol ^h^   1630           1639                            0.2                  tr     RI,MS
  148   *epi*-α -muurolol                       1635           1640                                   tr     0.7    0.4    RI,MS
  149   α -muurolol                             1640           1644                                                 0.1    RI,MS
  150   α -eudesmol                             1636           1652                            0.5                         RI,MS
  151   intermedeol                             1639           1666                            0.1                         RI,MS
  152   α-cadinol                               1647           1652                                   tr     1.4    0.4    RI,MS
  153   ageratochromene                         1655           1658                                          0.8           RI,MS
  154   α-bisabolol                             1673           1685                   tr       0.4                         Std
  155   3-oxo-β-ionone                          1678           1685                                          0.9           RI,MS
  156   cyperotundone                           1688           1695                                          0.9           RI,MS
  157   (2*E*-6*Z*)-farnesol                    1709           1698                                          2.4           RI,MS
  158   curcuphenol                             1716           1717                                                 0.4    RI,MS
  159   (2*E*-6*Z*)-farnesal                    1718           1713                                          1.0           RI,MS
  160   (2*E*-6*E*)-farnesal                    1737           1740                                          1.7           RI,MS
  161   *n*-tricosane                           2300           2300                   0.1                                  Std
        Oil yield (%)                                                        0.01     0.3      0.2    2.0    0.4    1.8    
        Total identified (%)                                                 98.3     99.4     99.3   99.6   76.0   94.3   
        Grouped compounds (%)                                                                                              
        Monoterpene hydrocarbons                                                      14.9     59.8   0.6    0.6    tr     
        Oxygenated monoterpenes                                                       83.3     11.0   0.3    50.6          
        Sesquiterpene hydrocarbons                                           97.4     0.2      20.0   5.2           54.7   
        Oxygenated sesquiterpenes                                                     0.4      8.4    0.2    12.1   39.6   
        Phenylpropanoids                                                                              84.0                 
        Others                                                               0.9      0.6             0.2    12.7          

^a^ Components are reported in order of their elution from an HP-5MS capillary column; ^b^ Retention index (RI) experimentally determined using a mixture of C~8~-C~30~ of n-alkanes; ^c^ Retention index taken from ADAMS \[[@B41-ijerph-14-00737]\] and/or NIST 08 \[[@B42-ijerph-14-00737]\] for an apolar capillary column; ^d^ Relative percentage values are means of three determinations with a Relative Standard Deviation (RSD%) below 15% for the most abundant components; ^e^ Analytical data are taken from Pavela et al. \[[@B26-ijerph-14-00737]\]; ^f^ Identification methods: standard (std), based on the comparison of RT (retention time), RI, and MS (mass spectronomy) with authentic compounds; RI, based on correspondence of calculated RI with those reported in ADAMS and NIST 08; MS, based on comparison with the WILEY, ADAMS, FFNSC2, and NIST 08 MS databases; ^g^ traces, % \<0.1; ^h^ Correct isomer not identified. ID: Identity.
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###### 

Inhibitory effects of essential oils from Cameroonian plants against *Trypanosoma brucei brucei* TC221 and Balb/3T3 cells.

  Treatment                 IC~50~ (µg/mL)             Selectivity Index (SI)   
  ------------------------- -------------------------- ------------------------ --------
  **Essential oils**                                                            
  *Aframomum danielli*      7.65 ± 1.1                 \>100                    \>13.1
  *Dichrostachys cinerea*   \>100                      \-                       \-
  *Echinops giganteus*      10.50 ± 1.7                \>100                    \>9.52
  *Azadirachta indica*      15.21 ± 0.97               \>100                    \>6.57
  *Aframomum melegueta*     \>100                      \-                       \-
  *Clausena anisata*        \>100                      \-                       \-
  **Pure compounds**        **µg/mL (µM)**             **µg/mL (µM)**           
  Sabinene                  5.96 ± 1.3 (43.8)          \>100                    \>16.7
  β-Pinene                  11.4 ± 2.6 (83.7)          \>100                    \>8.77
  1,8-Cineole               \>100                      \-                       
  Terpinen-4-ol             \>100                      \-                       
  (*E*)-Caryophyllene       8.25 ± 1.3 (40.4)          \>100                    \>12.1
  **Reference drug**        **µg/mL (µM)**             **µg/mL (µM)**           
  Suramin                   0.0286 ± 0.0008 (0.0220)   \-                       

IC**~50~:** half maximal inhibitory concentration.

[^1]: These authors contributed equally to this study.
